CNS:NYE-Cohen & Steers Inc (USD)

EQUITY | Asset Management | New York Stock Exchange

Last Closing

USD 71.64

Change

+0.19 (+0.27)%

Market Cap

USD 1.61B

Volume

0.61M

Analyst Target

USD 72.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Cohen & Steers Inc is an investment manager engaged in real assets, including real estate, infrastructure and commodities, along with preferred securities and other income solutions.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-21 )

Largest Industry Peers for Asset Management

Symbol Name Price(Change) Market Cap
BX Blackstone Group Inc

-0.84 (-0.67%)

USD 151.12B
BLK BlackRock Inc

-4.56 (-0.57%)

USD 118.72B
KKR KKR & Co LP

-0.05 (-0.05%)

USD 101.00B
APO Apollo Global Management LLC C..

+0.19 (+0.16%)

USD 67.30B
BN Brookfield Corp

-0.07 (-0.17%)

USD 64.16B
BK Bank of New York Mellon

-0.69 (-1.16%)

USD 44.48B
AMP Ameriprise Financial Inc

-2.22 (-0.50%)

USD 43.74B
ARES Ares Management LP

+1.50 (+1.12%)

USD 41.83B
OWL Blue Owl Capital Inc

N/A

USD 25.46B
STT State Street Corp

-0.36 (-0.49%)

USD 21.76B

ETFs Containing CNS

CP9G:LSE Amundi MSCI Pacific ex Ja.. 5.35 % 0.00 %

-170.00 (-1.28%)

USD 0.03B
CP9U:LSE Amundi MSCI Pacific ex Ja.. 5.35 % 0.00 %

-2.94 (-1.28%)

USD 0.03B
MPXG:LSE Amundi Index MSCI Pacific.. 5.26 % 0.00 %

-14.50 (-1.28%)

USD 4.92M
CP9:PA Amundi Index MSCI Pacific.. 4.91 % 0.00 %

-1.80 (-1.28%)

USD 0.31B
18MM:F Amundi Funds - Amundi Ind.. 4.91 % 0.00 %

N/A

N/A
18MM:XETRA Amundi Index MSCI Pacific.. 4.91 % 0.00 %

-1.50 (-1.28%)

USD 0.32B
APXJ:XETRA Amundi Index MSCI Pacific.. 4.91 % 0.00 %

-0.01 (-1.28%)

USD 0.61B
CYBG:LSE VanEck Bionic Engineering.. 4.69 % 0.00 %

-0.22 (-1.28%)

USD 6.25M
FAIR:AU BetaShares Australian Sus.. 4.60 % 0.00 %

+0.20 (+-1.28%)

USD 1.50B
CIB0:XETRA VanEck Bionic Engineering.. 4.51 % 0.00 %

-0.19 (-1.28%)

USD 6.26M
FDHT 3.41 % 0.00 %

N/A

N/A
OZXX:AU Global X Australia Ex Fin.. 2.97 % 0.00 %

+0.02 (+-1.28%)

N/A
GRNV:AU VanEck MSCI Australian Su.. 2.95 % 0.00 %

+0.31 (+-1.28%)

USD 0.17B
BATF:XETRA L&G Asia Pacific ex Japan.. 2.50 % 0.00 %

-0.05 (-1.28%)

USD 3.84M
EX20:AU BetaShares Australian Ex-.. 2.43 % 0.00 %

+0.15 (+-1.28%)

USD 0.27B
IESG:AU iShares Core MSCI Austral.. 2.26 % 0.00 %

+0.33 (+-1.28%)

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.25 % 0.00 %

-0.06 (-1.28%)

USD 0.05B
MEDTE:PA BNP Paribas Easy ECPI Glo.. 2.25 % 0.00 %

-0.05 (-1.28%)

N/A
MTUSD:PA BNP Paribas Easy ECPI Glo.. 2.25 % 0.00 %

+0.01 (+-1.28%)

N/A
AUMF:AU iShares Edge MSCI Austral.. 1.97 % 0.00 %

N/A

USD 0.07B
DGRS WisdomTree U.S. SmallCap .. 1.83 % 0.38 %

-0.68 (-1.28%)

USD 0.36B
WELP:LSE HAN-GINS Indxx Healthcare.. 0.00 % 0.00 %

-7.10 (-1.28%)

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (Asset Management) Market Performance vs. Exchange (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.40% 7% C- 23% F
Dividend Return 1.56% 9% A- 48% F
Total Return -3.84% 8% B- 23% F
Trailing 12 Months  
Capital Gain 29.29% 94% A 85% B
Dividend Return 4.19% 27% F 60% D-
Total Return 33.48% 92% A 86% B+
Trailing 5 Years  
Capital Gain 39.84% 94% A 68% D+
Dividend Return 28.38% 45% F 84% B
Total Return 68.22% 94% A 76% C+
Average Annual (5 Year Horizon)  
Capital Gain 5.42% 85% B 60% D-
Dividend Return 9.63% 80% B- 64% D
Total Return 4.21% 30% F 74% C
Risk Return Profile  
Volatility (Standard Deviation) 24.28% 24% F 43% F
Risk Adjusted Return 39.66% 72% C 61% D-
Market Capitalization 1.61B 92% A 72% C

Key Financial Ratios

  Ratio vs. Industry/Classification (Asset Management) Ratio vs. Market (New York Stock Exchange)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 20.60 18% 26%
Price/Book Ratio 9.09 4% 9%
Price / Cash Flow Ratio 18.58 28% 18%
Price/Free Cash Flow Ratio 18.13 20% 17%
Management Effectiveness  
Return on Equity 29.79% 97% 91%
Return on Invested Capital 34.82% 94% 95%
Return on Assets 15.32% 99% 98%
Debt to Equity Ratio N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector